© 2021 MJH Life Sciences and HCPLive. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive. All rights reserved.
December 09, 2020
Approximately 30% of patients treated with upadacitinib achieved endoscopic mucosal improvement at week 8, compared to just 7% of the placebo group
December 04, 2020
This combination therapy may have a few advantages over standard corticosteroid regimens.
December 03, 2020
Despite the difficult circumstances, experts believe colorectal cancer rates will not decrease in the coming years due to delays in screenings.
December 02, 2020
The top-line results from the ABX464 study conducted in 15 European countries, as well as the US and Canada, are expected during the second quarter of 2021.
November 29, 2020
Inflammatory bowel disease patients were surveyed about their remission or flare-up status, as well as their expectations for a flare-up over the next 2 months.
November 09, 2020
Life expectancy rates were lower in patients with IBD when compared to a healthy control group.
October 29, 2020
Female gender, Caucasian race, and older age were all significantly associated with microscopic colitis.
Tunneled catheters resulted in lower rates of deep vein thrombosis when compared to PICCs.
Over the course of the 19 year review, biologic use has increased, while the prevalence of colectomies has decreased.
October 28, 2020
A new study demonstrates that vedolizumab is associated with real-world corticosteroid-free response and remission in patients with ulcerative colitis and Crohn’s disease.